Paclitaxel | Docetaxel | Irinotecan | 10-DAB III | Baccatin | Sequoyitol | (2R,3S)-3-Phenylisoserine Hydrochloride | (4S,5R)-3-(tetra-butoxycarbonyl)-2,2-dimethyl-4-phenyl-oxazolidine-5-carboxylic acid | (4S,5R)-3-(3-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid--Shanghai Jinhe Bio-Tech Co., Ltd.

用户名：

密　码：

Mr. Zhang Weizhong wins the prize of “Shanghai Excellent Entrepreneur for Invention Implement”.

Mr. Zhang Weizhong won the prize of “Shanghai Excellent Entrepreneur for

Invention Implement”. This prize is organized by Shanghai Invention

Association, in order to promoting creation and practicing for Invention. The

Association evaluated dozens of Entrepreneurs. Mr. Zhang Weizhong, Jinhe

Bio-Tec’s General Manager finally obtained this honor. The result has

been published on 23rd June 2006.

	Welcome to visit us during CPHI-SHANGHAI2008 at our booth: 4F32.
	Welcome to visit us during CPHI-SHANGHAI2008 at our booth: C36.
	Welcome to visit us during CPHI-SHANGHAI2008 at our booth: CP51083.
	Our Project Docetaxel is ranked as Innovation fund for Technology Based Firms Projects.
	Jinhe, was granted as the honor of “2005-2006 year’s advanced private enterprise “
	Mr. Zhang Weizhong, the General Manager of Jinhe Bio-tec is entitled as “Science and Technology Hero”.
	Jinhe’s research and development center was set up in Shanghai Juke Bio-tech Park
	Mr. Zhang Weizhong wins the prize of “Shanghai Excellent Entrepreneur for Invention Implement”.
	A new patent of Jinhe Bio-Tec called “a new method of Docetaxel synthesis” was published.